BioNTech

IPO initial public offering
Biotech

BioNTech backing powers DualityBio toward $200M Hong Kong IPO

Backers including BioNTech have committed around one-third of the targeted IPO haul, putting DualityBio on course to raise cash for its ADC pipeline.
Nick Paul Taylor Apr 7, 2025 8:21am
Sketch of lungs

BioNTech posts survival data behind bispecific's phase 3 push

Mar 28, 2025 8:00am
Yellow arrow going opposite direction as white arrows

BioNTech passes on Autolus' CAR-T amid pipeline prioritization

Mar 20, 2025 9:11am
pause halt pause button

FDA slaps hold on BioNTech's malaria vaccine trial

Mar 4, 2025 5:30pm
breast cancer mammogram

BioNTech posts overall survival data on would-be Keytruda killer

Dec 10, 2024 9:00am
steps race jump stairs climb

Chasing Merck, BioNTech, DualityBio post first data on ADC

Dec 6, 2024 9:07am